Department of Pharmacology, The University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd., Dallas, Texas 75390, United States.
Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd., Dallas, Texas 75390, United States.
ACS Infect Dis. 2020 May 8;6(5):1058-1075. doi: 10.1021/acsinfecdis.9b00455. Epub 2020 Apr 24.
Little is known about the role of the three Jumonji C (JmjC) enzymes in (). Here, we show that JIB-04 and other established inhibitors of mammalian JmjC histone demethylases kill asexual blood stage parasites and are even more potent at blocking gametocyte development and gamete formation. In late stage parasites, JIB-04 increased levels of trimethylated lysine residues on histones, suggesting the inhibition of Jumonji demethylase activity. These epigenetic defects coincide with deregulation of invasion, cell motor, and sexual development gene programs, including gene targets coregulated by the PfAP2-I transcription factor and chromatin-binding factor, PfBDP1. Mechanistically, we demonstrate that PfJmj3 converts 2-oxoglutarate to succinate in an iron-dependent manner consistent with mammalian Jumonji enzymes, and this catalytic activity is inhibited by JIB-04 and other Jumonji inhibitors. Our pharmacological studies of Jumonji activity in the malaria parasite provide evidence that inhibition of these enzymatic activities is detrimental to the parasite.
目前对于三种 Jumonji C (JmjC) 酶在()中的作用知之甚少。在这里,我们表明 JIB-04 和其他已建立的哺乳动物 JmjC 组蛋白去甲基酶抑制剂可杀死无性血期寄生虫,并且在阻止配子体发育和配子形成方面更为有效。在晚期寄生虫中,JIB-04 增加了组蛋白上赖氨酸三甲基化残基的水平,表明抑制了 Jumonji 去甲基酶活性。这些表观遗传缺陷与入侵、细胞运动和性发育基因程序的失调相吻合,包括 PfAP2-I 转录因子和染色质结合因子 PfBDP1 共同调控的基因靶标。在机制上,我们证明 PfJmj3 以依赖铁的方式将 2-氧戊二酸转化为琥珀酸,这与哺乳动物 Jumonji 酶一致,并且该催化活性被 JIB-04 和其他 Jumonji 抑制剂抑制。我们对疟原虫中 Jumonji 活性的药理学研究提供了证据,表明抑制这些酶活性对寄生虫有害。